.png)
US direct sales market leader Amway will pump in USD 12 million (approximately Rs 100 crore) in India in the next three to five years to augment retail reach and deepen distribution network. The decision is in line with Amway's increasing focus...
The U.S. Food and Drug Administration (FDA) has given approval to Lynkuet (elinzanetant), Bayer's dual neurokinin (NK) receptor antagonist that is not accompanied by the use of hormones
Salesforce India has introduced Agentforce Life Sciences for Customer Engagement, expanding its Agentforce Life Sciences portfolio with an innovative, agent-first solution designed to transform how life sciences organizations connect with healthcare
Eli Lilly announced on Tuesday that it is partnering with NVIDIA to create a supercomputer aimed at expediting drug discovery and reducing development timelines, thereby allowing the company to provide medications to patients more swiftly
Alembic Pharmaceuticals Limited (Alembic) declares that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ticagrelor Tablets, 60 mg.
The fifth edition of the Pink Mela - a unique and vibrant event dedicated to raising awareness about breast cancer, brought together entertainment and education for women in Nashik. Organized jointly by HCG Manavata Cancer Centre (HCGMCC) and...
.png)
Akums Drugs & Pharmaceuticals Ltd. has commenced the construction of its first global manufacturing facility in Zambia, representing a significant advancement in its international expansion efforts. The ceremonial groundbreaking was initiated...
In an exclusive interview with Thiruamuthan, Assistant Editor of India Pharma Outlook, Jordan Kohlbeck, Head of Pharmaceuticals at IAG Cargo, discusses how India’s growing role as a global pharmaceutical exporter is driving transformation in the air
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, is presenting preclinical data on RVU305
IOL Chemicals & Pharmaceuticals Limited (IOLCP) is proud to announce an important milestone in their pharmaceutical division after being awarded a Certificate of Suitability
.jpg)
, CDSCO.jpg)